Latest News Archive
Please select Category, Year, and then Month to display items
31 December 2019
|
Story Dr Cindé Greyling
|
Photo Anja Aucamp
Dr Mariana Erasmus, SAENSE Platform Manager, says water remediation is vital for both the ecosystem and industries.
KovsieInnovation at the UFS supports innovative research outputs in various ways – one of which is to protect the intellectual property and to register patents where viable. This is in line with KovsieInnovation’s broader aim to create third-stream income for the university. Patent registration is a complex process and the UFS is proud to have the needed expertise to properly facilitate such an endeavour.
The SAENSE Platform
South Africa is a water-scarce country, with many water hungry industries (such as agriculture and mining). “Industrial processes often contaminate water with heavy metals, harmful chemicals, radioactive waste, and even organic sludge,” Dr Mariana Erasmus, SAENSE Platform Manager, explains.
Hence, water remediation is vital for both the ecosystem and industries. One of the key functions of the SAENSE Platform is to offer water-remedial solutions for the (bio)remediation of nitrates, heavy metals, and salts, among others. The platform’s activities and services are supported by undergraduate and postgraduate students and researchers, using Technology Innovation Agency (TIA) funding. TIA is a national public entity that serves as key institutional intervention to bridge the innovation chasm between research and development.
From waste to water
Through the joint effort of two mining companies and the UFS/TIA SAENSE Research Platform, a new treatment for mine drainage (MD) has been developed. This patented B-DAS (Barium – Dispersed Alkaline Substrate) technology effectively treats the major contaminants found in acid, alkaline, or neutral mining wastewater. The aim of the B-DAS system is to provide a passive water-treatment solution with minimum waste production; it can also be a potential pre-treatment for reverse osmosis (RO) to lower the requirements of the membranes and therefore potentially reduce the RO cost.
The success of the patent is that it turns unusable water into water that is fit for agricultural purposes at a reduced cost and increased efficiency.
Otorhinolaryngology research hopes to decrease morbidity
2016-10-04
Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS
Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.
He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.
Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.
The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.
Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.
“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.
“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.